Investigating neuroinflammation in Alzheimer's disease using specialized imaging techniques
Probing neuroinflammation in Alzheimer's disease with NLRP3 PET radiotracers
This study is looking at how inflammation in the brain affects Alzheimer's disease and aims to create a new way to see this inflammation using special imaging techniques, which could help improve how we diagnose and treat the condition for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-10659920 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of neuroinflammation in Alzheimer's disease (AD) by developing a new biomarker that can be detected using positron emission tomography (PET) radiotracers. The study aims to explore the NLRP3 inflammasome, a key player in the immune response, to monitor inflammation in the brains of AD patients. By creating small molecule inhibitors that target NLRP3, the research seeks to improve diagnosis and treatment evaluation for Alzheimer's. Patients may benefit from enhanced imaging techniques that could lead to better therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease who are experiencing symptoms related to neuroinflammation.
Not a fit: Patients with other forms of dementia or neurodegenerative diseases unrelated to neuroinflammation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new way to diagnose and monitor Alzheimer's disease, potentially leading to improved treatment outcomes.
How similar studies have performed: Previous research has shown promise in using similar imaging techniques to study neuroinflammation in other neurodegenerative diseases, indicating potential for success in this novel approach.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Zhang, Shijun — Virginia Commonwealth University
- Study coordinator: Zhang, Shijun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.